Luzerne Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.14 Cr
- Paid Up Capital ₹ 1.14 Cr
- Company Age 10 Year, 5 Months
- Last Filing with ROC 31 Mar 2020
- Open Charges ₹ 1.08 Cr
- Revenue Growth 42.51%
- Profit Growth -23.62%
- Ebitda 186.34%
- Net Worth 19.63%
- Total Assets 96.02%
About Luzerne Life Sciences
Luzerne Life Sciences Private Limited (LLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 September 2014 and has a history of Ten years and five months. Its registered office is in Ernakulam, Kerala, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 1.14 Cr and a paid-up capital of Rs 1.14 Cr.
The company currently has active open charges totaling ₹1.08 Cr.
Deepu Mathew and Sajin Stalin serve as directors at the Company.
Company Details
-
Location
Ernakulam, Kerala, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U33110KL2014PTC037223
-
Company No.
037223
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
04 Sep 2014
-
Date of AGM
31 Dec 2020
-
Date of Balance Sheet
31 Mar 2020
-
Listing Status
Unlisted
-
ROC Code
Roc Ernakulam
Industry
Who are the key members and board of directors at Luzerne Life Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deepu Mathew
|
Managing Director | 23-Aug-2019 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Sajin Stalin
|
Director | 23-Aug-2019 | Current |
Financial Performance of Luzerne Life Sciences.
Luzerne Life Sciences Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 42.51% increase. The company also saw a substantial fall in profitability, with a 23.62% decrease in profit. The company's net worth Soared by an impressive increase of 19.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Luzerne Life Sciences?
In 2020, Luzerne Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Delvin Klarvoyant Biogenics Private LimitedDeepu Mathew is a mutual person
-
Biolife Logistics Private Limited
Deepu Mathew is a mutual person
Charges (Loans)
₹1.08 Cr
₹0
Charges Breakdown by Lending Institutions
- Canara Bank : 1.08 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Apr 2021 | Canara Bank | ₹1.45 M | Open |
| 23 Apr 2021 | Canara Bank | ₹1.80 M | Open |
| 09 Jul 2015 | Canara Bank | ₹7.50 M | Open |
How Many Employees Work at Luzerne Life Sciences?
Luzerne Life Sciences has a workforce of 2 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Luzerne Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Luzerne Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
